Clinical Trial Update: Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma [NA]

View source ↗

Summary

A completed clinical trial comparing cytoreductive surgery plus transarterial chemoembolization (TACE) versus TACE alone for hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Cytoreductive Surgery
• Transarterial chemoembolization (chemotherapy with embolization (various agents))

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Hepatocellular Carcinoma | NA | Status: COMPLETED